This variation affects:
Other names:
rs2231142 is a genetic variant on gene ABCG2 associated with Gout and Hyperuricemia.
This variant is located on chromosome 4. The variations at position 88131171 are the genetic letters A/A, G/G, T/T, C/G, G/T, A/G
Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs2231142 there are 6 currently known genotypes : A/A, G/G, T/T, C/G, G/T or A/G
rs2231142 is located on gene ABCG2 in chromsome 4. Use the genome browser to explore the location of rs2231142 and its genetic neighbourhood.
rs2231142 affects the following conditions and traits:
rs2231142 affects the following conditions:
rs2231142 affects the following drugs:
rs2231142 is commonly tested together with other variants on the same gene.
This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs on gene ABCG2. Explore more variants and their effects on the body by browsing left and right along the DNA strand.
Mutations are random changes in the DNA and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.
Dr. Wallerstorfer
The different genotypes of variant rs2231142 can affect the expression or likelyhood of developing certain traits or conditions. Current research shows that 4 conditions and 0 traits are associated with rs2231142. The following table shows the relationship between genotypes and conditions and traits.
Genetic variants can influence how our body reacts to certain drugs. The presence of specific genetic variants can increase or decrease the efficiency and effectiveness of a drug, impacting how well it works inside our system. Additionally, certain genetic variants can heighten or lessen the toxicity of a drug, thereby affecting the risk of unwanted side effects. They can also alter how a drug is metabolized, which influences the appropriate dosage one should receive.
Dr. Wallerstorfer
Clinical testing classifications are designed to help doctors understand how genetic changes, known as variants, might affect a person’s health and guide medical decisions. Variants are labeled as Disease Causing (harmful), likely Disease Causing, Unknown Effect (unknown impact), Likely No Effect (likely not harmful), and No Effect (not harmful). This classification relies on a mix of family history, lab tests, and computer predictions to determine the impact of variants.
Variants can have different effects based on their location. Variants on the X chromosome often impact males more because they have only one X chromosome, while females have two. This influences the classification (effect) of the variant.
Clinical Testing
Scientific Studies
Biological Male Symbol
Biological Female Symbol
Unisex Symbol for both Genders
Genotype
G
G
Level of evidence
No Effect
Unisex
1 Sources
Participants: 0
The genotype with the letters G/G is thought to have no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
T
T
Level of evidence
Unknown effect
Unisex
1 Sources
Participants: 0
The genotype with the letters T/T has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
G
T
Level of evidence
Unknown effect
Unisex
1 Sources
Participants: 0
The genotype with the letters G/T has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
G
G
Level of evidence
No Effect
Unisex
1 Sources
Participants: 0
The genotype with the letters G/G is thought to have no effect on your disease risk. Carriers of this genetic result are usually not at risk of developing the disease.
Genotype
T
T
Level of evidence
Unknown effect
Unisex
1 Sources
Participants: 0
The genotype with the letters T/T has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Genotype
G
T
Level of evidence
Unknown effect
Unisex
1 Sources
Participants: 0
The genotype with the letters G/T has an unknown effect on your disease risk. This means that the scientific evidence is still somewhat unclear about its effect.
Scientific studies classifications aim to uncover how genetic variants function and their roles in diseases, traits, and evolution. Variants are categorized based on their functional impact, such as loss-of-function (reduces gene activity), gain-of-function (increases gene activity), neutral (no significant impact), or evolutionary conservation. This classification uses experimental data, population studies, and computational analyses to understand variant effects. Unlike clinical testing, which focuses on immediate health impacts, scientific studies explore broader genetic mechanisms and long-term implications.
Genotype
T
T
Level of evidence
Increased likelihood
Unisex
4 Sources
Participants: 409764
The genotype with the letters T/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
T
Level of evidence
Increased likelihood
Unisex
4 Sources
Participants: 409764
The genotype with the letters G/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
T
T
Level of evidence
Increased likelihood
Unisex
4 Sources
Participants: 409764
The genotype with the letters T/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
Genotype
G
T
Level of evidence
Increased likelihood
Unisex
4 Sources
Participants: 409764
The genotype with the letters G/T is considered a risk factor for developing the disease. Carriers of this genetic result are at increased risk of developing the disease.
The genetic variant rs2231142 impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with rs2231142. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Drug Effect to ALLOPURINOL.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have decreased Drug Effect to ALLOPURINOL.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have decreased Drug Effect to ALLOPURINOL.
more info
Legend:
Increased
Decreased
No known effect
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Breakdown to APIXABAN.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have increased Breakdown to APIXABAN.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have decreased Breakdown to APIXABAN.
more info
Legend:
Increased
Decreased
No known effect
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have decreased Drug Effect to CAPECITABINE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have increased Drug Effect to CAPECITABINE.
more info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have increased Drug Effect to CAPECITABINE.
more info
Legend:
Increased
Decreased
No known effect
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Drug Effect to ALLOPURINOL.
More info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have decreased Drug Effect to ALLOPURINOL.
More info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have decreased Drug Effect to ALLOPURINOL.
More info
Legend:
Increased
Decreased
No known effect
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have increased Breakdown to APIXABAN.
More info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have increased Breakdown to APIXABAN.
More info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have decreased Breakdown to APIXABAN.
More info
Legend:
Increased
Decreased
No known effect
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have decreased Drug Effect to CAPECITABINE.
More info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/T have increased Drug Effect to CAPECITABINE.
More info
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype T/T have increased Drug Effect to CAPECITABINE.
More info
Legend:
Increased
Decreased
No known effect
rs2231142 is commonly tested together with other variants on the same gene.
Conditions and traits are often affected by more than one variant. It is important to understand these other factors to get a better understanding of how genetics affect certain conditions and traits. The following grid shows other variants that affect the same conditions and traits as rs2231142.
Knowing your genome can actually tell you a lot about your ancestors.
The prevalence of the different genotypes is based on the native inhabitants of a region. In the map below you see how common each genotype is in the native inhabitants of those regions. Since genetic material is passed down form generation to generation, your DNA shows traces of the geographical origins of your ancestors.
This data is based on “The 1000 Genomes Project” which established one of the most detailed overviews of human genetic variations across the globe. The regions are broadly categorized into five continental groups: Africa, America, Europe, South Asia and East Asia. All continental groups together display the global prevalence. Click through the regions, to learn more about the local prevalence of the possible genotypes.
At present, there is no distribution data available for SNP 2231142. 2231142.
All of the resources below examine variant rs
Ke Wang, Murray Cadzow, Matt Bixley, Megan P Leask, Marilyn E Merriman, Qiangzhen Yang, Zhiqiang Li, Riku Takei, Amanda Phipps-Green, Tanya J Major, Ruth Topless, Nicola Dalbeth, Frances King, Rinki Murphy, Lisa K Stamp, Janak de Zoysa, Zhuo Wang, Yongyong Shi, Tony R Merriman
Benjamin Lai, Huang-Ping Yu, Yu-Jing Chang, Liang-Chin Wang, Che-Kai Chen, Weiya Zhang, Michael Doherty, Shang-Hung Chang, Jun-Te Hsu, Kuang-Hui Yu, Chang-Fu Kuo
Mohammad A. Alshabeeb, Mesnad Alyabsi, Mohammad A. Aziz, Salah Abohelaika